Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer

Stopped Study terminated due to reproducibility issues with genomics prediction model.

Conditions

• Carcinoma, Non-Small-Cell Lung

Interventions

• DRUG: Vinorelbine followed by Cisplatin
• DRUG: Pemetrexed followed by Cisplatin

Sponsor

Duke University

Collaborators

• [object Object]